Gross Profit for Regeneron Pharmaceuticals (REGN)
According to Regeneron Pharmaceuticals's latest reported financial statements, the company's current gross profit (TTM) is $12.24B USD. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingGross ProfitSwitch metric
TTM (last 4 quarters)
$12.24B
YoY change
+0.1%
5Y CAGR
+11.4%
Peak year (2021)
$13.35B
Cumulative gross profit
$99.01B
Gross Profit history chart for Regeneron Pharmaceuticals (REGN) from 1990 to 2025
Gross Profit history table for Regeneron Pharmaceuticals (REGN) from 1990 to 2025
| Fiscal year | Period ended | Reported | Gross Profit | YoY |
|---|---|---|---|---|
| 2025 | $12.24B | +0.1% | ||
| 2024 | $12.23B | +12.5% | ||
| 2023 | $10.87B | +3.9% | ||
| 2022 | $10.47B | -21.6% | ||
| 2021 | $13.35B | +86.9% | ||
| 2020 | $7.14B | +27.9% | ||
| 2019 | $5.58B | -8.9% | ||
| 2018 | $6.13B | +15.0% | ||
| 2017 | $5.33B | +19.6% | ||
| 2016 | $4.46B | +22.5% | ||
| 2015 | $3.64B | +41.9% | ||
| 2014 | $2.56B | +34.3% | ||
| 2013 | $1.91B | +51.8% | ||
| 2012 | $1.26B | +206.2% | ||
| 2011 | $410.53M | -6.1% | ||
| 2010 | $437.29M | +20.4% | ||
| 2009 | $363.33M | +60.6% | ||
| 2008 | $226.25M | — | ||
| 2007 | $0 | -100.0% | ||
| 2006 | $40.71M | -1.0% | ||
| 2005 | $41.13M | +81.1% | ||
| 2004 | $22.71M | -55.3% | ||
| 2003 | $50.82M | +227.8% | ||
| 2002 | $15.51M | +0.3% | ||
| 2001 | $15.46M | -64.6% | ||
| 2000 | $43.71M | +41.5% | ||
| 1999 | $30.90M | -6.9% | ||
| 1998 | $33.20M | +8.9% | ||
| 1997 | $30.50M | +32.6% | ||
| 1996 | $23.00M | -16.1% | ||
| 1995 | $27.40M | +18.1% | ||
| 1994 | $23.20M | +118.9% | ||
| 1993 | $10.60M | -7.8% | ||
| 1992 | $11.50M | -309.1% | ||
| 1991 | -$5.50M | +323.1% | ||
| 1990 | -$1.30M | — |
Gross Profit values are taken from Regeneron Pharmaceuticals's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Regeneron Pharmaceuticals (REGN) gross profit totalled $12.24B – edged up 0.1% year-over-year.
Regeneron Pharmaceuticals gross profit compound annual growth for the 2020–2025 (5 years) window is +11.4%, sustaining 3 straight years of year-over-year growth.
Regeneron Pharmaceuticals gross profit peaked at $13.35B in 2021; the latest annual figure is $12.24B in 2025 (8.3% below peak).
2021 marks the peak gross profit at $13.35B, with the historical low of -$5.50M recorded in 1991.
Within Healthcare, Regeneron Pharmaceuticals (REGN) ranks 9th among 8 peers we track. The peer median for gross profit is $53.80B.
Regeneron Pharmaceuticals Gross Profit by Year
Regeneron Pharmaceuticals Gross Profit 2025: $12.24B
Regeneron Pharmaceuticals gross profit in 2025 was $12.24B, edged up 0.1% from 2024.
Regeneron Pharmaceuticals Gross Profit 2024: $12.23B
Regeneron Pharmaceuticals gross profit in 2024 was $12.23B, grew 12.5% from 2023.
Regeneron Pharmaceuticals Gross Profit 2023: $10.87B
Regeneron Pharmaceuticals gross profit in 2023 was $10.87B, edged up 3.9% from 2022.
Regeneron Pharmaceuticals Gross Profit 2022: $10.47B
Regeneron Pharmaceuticals gross profit in 2022 was $10.47B, declined 21.6% below 2021.
Regeneron Pharmaceuticals Gross Profit 2021: $13.35B
Regeneron Pharmaceuticals gross profit in 2021 was $13.35B.
See more financial history for Regeneron Pharmaceuticals (REGN).
Sector peers — Gross Profit
Companies in the same sector as Regeneron Pharmaceuticals, ranked by their latest gross profit.
| Company | Gross Profit | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $250.28B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $82.92B | Healthcare |
| Johnson & Johnson (JNJ) | $68.56B | Healthcare |
| Eli Lilly and Company (LLY) | $54.62B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.98B | Healthcare |
| AstraZeneca PLC (AZN) | $48.11B | Healthcare |
| AbbVie Inc. (ABBV) | $42.96B | Healthcare |
| Amgen Inc. (AMGN) | $26.01B | Healthcare |
Frequently asked questions
What is Regeneron Pharmaceuticals's gross profit?
- Latest reported gross profit for Regeneron Pharmaceuticals (REGN) is $12.24B (period ending December 31, 2025).
How has Regeneron Pharmaceuticals gross profit changed year-over-year?
- Regeneron Pharmaceuticals (REGN) gross profit changed +0.1% year-over-year on the latest annual filing.
What is the long-term growth rate of Regeneron Pharmaceuticals gross profit?
- Regeneron Pharmaceuticals (REGN) gross profit compound annual growth rate is +11.4% over the most recent 5 years available.
When did Regeneron Pharmaceuticals gross profit hit its highest annual value?
- Regeneron Pharmaceuticals gross profit reached its highest annual value of $13.35B in 2021.
What was Regeneron Pharmaceuticals gross profit in 2024?
- Regeneron Pharmaceuticals (REGN) gross profit in 2024 was $12.23B.
What was Regeneron Pharmaceuticals gross profit in 2025?
- Regeneron Pharmaceuticals (REGN) gross profit in 2025 was $12.24B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
REGN Overview
Company profile, financial tools, and key metrics
REGN Revenue Counter
Earns $454.81 every second. See per minute, hour, and day.
REGN Earnings Counter
Earns $142.85 per second net profit. See per minute, hour, and day.
REGN Economic Scale
Exceeds Rwanda's GDP. Compare with world economies.
REGN What If Invested
What if you had invested $1,000? See historical returns from any date.
REGN How It Makes Money
Discover visual breakdown of $14.34B in revenue — where it comes from and where it goes.
REGN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
REGN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
REGN Daily Price Character
Explosive · 47.1% historical win rate (green days). Streaks & record days.
REGN Buybacks
4.33% TTM buyback yield. Shareholder yield & SBC comparison.
REGN Dividend Profile
Yield: 0.52%. See full history.
REGN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
REGN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.